Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-28 Sale |
2021-12-29 4:19 pm |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
231,431 | $38.25 | $8,852,236 | 0 (Indirect Direct) |
View |
| 2021-08-10 Purchase |
2021-08-10 8:06 pm |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO |
5,000 | $22.1 | $110,480 | 43,164 (Direct) |
View |
| 2020-09-01 Purchase |
2020-09-01 8:33 pm |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO |
10,000 | $18.06 | $180,597 | 22,300 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-22 Option Award |
2022-06-24 06:33 am |
N/A 2032-06-22 |
Oncorus Inc. | ONCR | FAMBROUGH DOUGLAS Director |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2022-06-24 06:30 am |
N/A 2032-01-03 |
Oncorus Inc. | ONCR | FAMBROUGH DOUGLAS Director |
0 | $0 | 15,000 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 4:16 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
13,750 | $0 | 272,681 (Direct) |
View |
| 2021-12-15 Tax Withholding |
2021-12-17 4:16 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
5,348 | $38.05 | 272,681 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 7:33 pm |
N/A 2027-01-03 |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
179,865 | $0 | 469,414 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 7:33 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
146,195 | $3.42 | 469,414 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 7:33 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer |
33,670 | $2.97 | 469,414 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 9:38 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO |
19,950 | $0 | 399,580 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-12 9:38 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO |
302,700 | $0 | 399,580 (Direct) |
View |
| 2021-01-08 Tax Withholding |
2021-01-12 9:38 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO |
6,159 | $23.29 | 399,580 (Direct) |
View |